• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Liver test abnormalities in asymptomatic and mild COVID-19 patients and their association with viral shedding time

    2022-11-29 06:44:46SiYiYuJiaRongXieJunJunLuoHongPengLuLeiXuJunJieWangXueQinChen
    World Journal of Hepatology 2022年11期

    Si-Yi Yu,Jia-Rong Xie,Jun-Jun Luo,Hong-Peng Lu,Lei Xu,Jun-Jie Wang,Xue-Qin Chen

    Abstract

    BACKGROUND

    Asymptomatic infections and mild symptoms are common in patients infected with the Omicron variant, and data on liver test abnormalities are rare.

    AIM

    To evaluated the clinical characteristics of asymptomatic and mild coronavirus disease 2019 (COVID-19) patients with abnormal liver test results.

    METHODS

    This retrospective study included 661 laboratory-confirmed asymptomatic and mild COVID-19 patients who were treated in two makeshift hospitals in Ningbo from April 5, 2022 to April 29, 2022. Clinical information and viral shedding time were collected, and univariate and multivariate logistic regression models were performed in statistical analyses.

    RESULTS

    Of the 661 patients, 83 (12.6%) had liver test abnormalities, and 6 (0.9%) had liver injuries. Abnormal liver tests revealed a reliable correlation with a history of liver disease (P < 0.001) and a potential correlation with male sex and obesity (P < 0.05). Elevated alanine aminotransferase was reliably associated with obesity (P < 0.05) and a history of liver disease (P < 0.001). Elevated aspartate transaminase (AST) was reliably correlated with a history of liver disease (P < 0.001), and potentially correlated with age over 30 years (P < 0.05). There was a reliable correlation between AST ≥ 2× the upper limit of normal and a longer viral shedding time, especially in mild cases.

    CONCLUSION

    Obesity and a history of liver disease are risk factors for liver test abnormalities. Being male and an older age are potential risk factors. Attention should be given to liver tests in asymptomatic and mild COVID-19 patients, which has crucial clinical significance for evaluating the viral shedding time.

    Key Words: COVID-19; Liver test abnormalities; Asymptomatic carriers; Mild cases; Viral shedding time;Risk factors

    INTRODUCTION

    Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This highly contagious disease poses a great threat to global public health. By September 2, 2022, the disease had resulted in 601189435 infections and 6475346 deaths[1]. In addition to respiratory symptoms and fever, 14%-69% of patients with COVID-19 have abnormal liver function tests, mainly manifested by elevations of hypoalbuminemia, gamma-glutamyl transferase, alanine aminotransferase (ALT) and aspartate aminotransferase (AST)[2,3]. Patients with severe diseases are more likely to develop elevated liver tests, suggesting an association between liver injury and the severity of disease[2,4]. Possible mechanisms of COVID-19-related liver injury include direct SARSCoV-2-induced cytopathic injury to hepatocytes and cholangiocytes, immune dysregulation and hypoxic liver injury, and drug-induced liver injury[5].

    The Omicron B.1.1.529 (BA.1) variant was first discovered in South Africa on November 9, 2021[6]. Omicron variants have rapidly replaced delta variants due to their strong interpersonal infectivity, which has caused a worldwide pandemic. Compared with patients infected with previous variants, those infected with the Omicron variants are younger, have fewer comorbidities, and develop lower severity and mortality, and asymptomatic infections and mild symptoms are more common[7-9]. However, no studies have systematically focused on liver abnormalities in asymptomatic carriers or mild cases. Previous studies have revealed that liver test abnormalities are associated with prolonged hospitalization time and viral shedding time in COVID-19 patients[10,11], indicating a prognostic indicator of poor outcome. At present, no studies have examined the association between liver abnormalities and viral shedding time in asymptomatic and mild COVID-19 patients.

    The epidemic prevention policies of different countries are established based on their own political, economic and health conditions, which are in line with the national circumstances and none is superior to others. This study was carried out under the policy of Chinese government, aiming to determine the clinical characteristics of liver test abnormalities in asymptomatic and mild COVID-19 patients infected with the Omicron BA2.2 variant[12] and their association with the viral shedding time. Our research provides suggestions for health policymakers and medical practitioners.

    MATERIALS AND METHODS

    Participants

    In this cross-sectional study, we recruited patients with COVID-19 who were treated in Ningbo Makeshift Hospital and Dapengshan Makeshift Hospital in Ningbo, Zhejiang from April 5, 2022 to April 29, 2022. All patients were transferred from Shanghai. The inclusion criteria were as follows: (1) Age over 14 years; (2) complete clinical information; and (3) asymptomatic carriers or mild cases of COVID-19. Asymptomatic carriers were those who had positive etiological tests of COVID-19 but with no clinical symptoms or imaging features of COVID-19. Mild cases were defined as confirmed cases with mild clinical symptoms and no pneumonia manifestation on imaging[13]. The exclusion criteria were as follows: (1) Ordinary cases whose pneumonia manifestation could be seen in imaging, or severe cases with respiratory distress[13]; and (2) patients who were transferred to designated hospitals for further diagnosis and treatment due to underlying diseases or other reasons. This study complied with the Declaration of Helsinki and was approved by the Ethics Committee of Ningbo First Hospital (No. 2022RS069).

    Measures

    The clinical information of patients, including age, sex, height, weight, symptoms, medical history (hypertension, diabetes, and liver diseases), and laboratory tests (complete blood count, liver tests, chest computed tomography (CT) scans, and nucleic acid tests for COVID-19), were retrospectively collected. Obesity was defined as a body mass index (BMI) ≥ 28 kg/m2. Symptoms included fever, fatigue (weakness and muscle soreness), respiratory symptoms (sore throat, dry throat, cough, and chest stuffiness), and gastrointestinal symptoms (nausea, anorexia, and diarrhea). The patients’ symptoms were collected from the electronic medical records, and were double-checked on the day of discharge. Liver diseases included chronic hepatitis B, alcoholic/nonalcoholic fatty liver disease (NAFLD) and other liver diseases. NAFLD was defined as hepatic steatosis detected by ultrasound or CT, excluding secondary causes and excessive alcohol consumption (> 30 g/d for males, and > 20 g/d for females). Hepatitis B was defined as positive serum hepatitis B surface antigen. Complete blood counts, liver and kidney tests, and chest CT scans were performed on the admission day, and nasal swabs for SARS-CoV-2 were tested every two days. All patients received Chinese medicine and symptomatic therapy (if necessary), but not antivirals or monoclonal antibodies.

    Real-time reverse transcription PCR was used to detect SARS-CoV-2, and primers targeting the open reading frame 1ab (ORF1ab) and nucleocapsid protein N were used for amplification and detection. The corresponding sequences for ORF1ab were 5'-CCCTGTGGGTTTTACACTTAA-3'(F), 5'-ACGATTGTGCATCAGCTGA-3' (R), and 5'-CY3-CCGTCTGCGGTATGTGGGAAAGGTTATGG-BHQ1-3' (probe), and those for N were 5'-GGGGAACTTCTCCTGCTAGAAT-3' (F), 5'-CAGACATTTTGCTCTCAAGCTG-30' (R), and 5'-FAM-TTGCTGCTGCTTGACAGATT-TAMRA-3' (probe). The methods were based on the criteria provided by the National Health Commission of the People’s Republic of China[14].

    Liver test abnormalities were defined as elevations of the following liver enzymes in serum: ALT > 50 U/L (male) or 40 U/L (female), AST > 40 U/L (male) or 35 U/L (female), and total bilirubin (TBIL) > 17.1 μmol/L. Liver injury was defined as ALT and/or AST more than 3× the upper limit of normal (ULN) and/or TBIL more than 2 × ULN[15].

    Viral shedding was defined as the cycle threshold (Ct) values of both ORF1ab and N greater than 35. The viral shedding time was defined as the duration from the first positive nucleic acid test to the first negative result (two consecutive negatives). Patients were discharged with significantly recovered respiratory symptoms and two consecutive negative nucleic acid tests.

    Statistical analysis

    Data were analyzed by IBM SPSS (version 26.0). Continuous variables were described by the means ± standard deviation (SD) or medians and interquartile range (IQR), while categorical variables were described by the frequency and percentage. For continuous variable comparison, independent sample T tests or one-way analysis of variance were used for normally distributed data, and Mann–Whitney U tests or Kruskal–Wallis tests were used for nonnormally distributed data. For categorical variable comparison, chi-square tests or Fisher's exact tests were applied. Ordinal logistic regression analyses were used to identify risk factors associated with liver test abnormalities, and multiple linear regression analyses were used to identify factors associated with the viral shedding time. P < 0.05 (two-sided) was considered statistically significant. The results of statistical ayalyses can be re-verified if any party wishes to confirm the credibility.

    RESULTS

    Study design and participant criteria

    The participant recruitment process is shown in Figure 1. In total, 429 patients in Ningbo Makeshift Hospital and 256 patients in Dapengshan Makeshift Hospital were selected according to the inclusion criteria. Excluding 17 ordinary cases and 7 patients who were transferred to designated hospitals (4 cases of pulmonary tuberculosis diagnosed with CT scan, one case of acute asthma attack, one case of acute appendicitis, and one case of persistent abdominal pain), 661 participants were included in the final sample.

    Figure 1 Inclusion flow chart.

    As shown in Table 1, the median age was 33 years (IQR 27-44 years), 331 (50.1%) were male, and the median BMI was 22.8 kg/m2(IQR 20.7-25.2). A total of 130 (19.7%) had underlying diseases, of whom 57 (8.6%) had liver diseases. 45 (6.8%) had NAFLD, 11 (1.7%) had hepatitis B, and 1 (0.2%) had both. A total of 425 (64.3%) patients developed a fever, and 619 (93.6%) patients had mild cases. Eighty-three (12.6%) patients had liver test abnormalities and 6 (0.9%) had liver injuries. The number of patients with elevations in ALT, AST and TBIL was 53 (8.0%), 61 (9.2%), and 4 (0.6%), respectively, with a majority of mild liver test abnormalities (Supplementary Table 1). Some patients reported medicines taken before admission, including traditional Chinese medicine (382, 57.8%), nonsteroidal anti-inflammatory drugs (NSAIDs) (89, 13.5%), and other medicines for cold (91, 13.8%).

    Table 1 Characteristics of 661 patients with coronavirus disease 2019 by liver tests

    Clinical features of COVID-19 patients with liver test abnormalities

    As shown by a univariate logistic regression model, liver test abnormalities were significantly associated with male sex [odds ratio (OR) 1.699, 95% confidence interval (CI) 1.061-2.721, P = 0.027], obesity (OR 2.707, 95%CI 1.384-5.291, P = 0.004) and a history of liver disease (OR 2.707, 95%CI 1.384-5.291, P = 0.004) but not with age, disease type, clinical manifestations or medication history (Figure 2). The correlated factors in the univariate model were taken as key factors. A multivariate logistic regression model for key factors indicated that liver test abnormalities were only associated with a history of liver disease (OR 8.004, 95%CI 4.319-14.835, P < 0.001). A multivariate logistic regression model for all factors showed that liver test abnormalities were significantly associated with the age of 30-49 years (compared with age 14-30 years, OR 1.970, 95%CI 1.073-3.618, P = 0.029), male sex (OR 1.728, 95%CI 1.005-2.971, P = 0.048), and a history of liver disease (OR 8.265, 95%CI 4.315-15.831, P < 0.001). Based on the above models, liver test abnormalities had a reliable correlation with a history of liver disease, and a potential correlation with male sex and obesity.

    As revealed by all three models in Supplementary Figure 1, elevated ALT had a firm correlation with obesity (univariate logistic regression: OR 3.82, 95%CI 1.84-7.94, P < 0.001; multivariate logistic regression for key factors: OR 2.57, 95%CI 1.15-5.70, P = 0.021; multivariate logistic regression for all factors: OR 3.31, 95%CI 1.37-7.98, P = 0.009) and a history of liver disease (univariate logistic regression: OR 9.54, 95%CI 5.01-18.16, P < 0.001; multivariate logistic regression for key factors: OR 8.30, 95%CI 4.21-16.36, P < 0.001; multivariate logistic regression for all factors: OR 9.05, 95%CI 4.31-19.01, P < 0.001). Therefore, ALT elevation was reliably correlated with obesity and a history of liver disease.

    A univariate logistic regression model indicated that elevated AST was associated with a history of liver disease (OR 8.18, 95%CI 4.40-15.24, P < 0.001, Supplementary Figure 2). A multivariate logistic regression model on all factors showed that AST elevation was associated with older age (age of 30-49 years vs age of 14-29 years: OR 2.48, 95%CI 1.18-5.20, P = 0.016; age over 50 years vs. age of 14-29 years: OR 2.81, 95%CI 1.14-6.97, P = 0.025) and a history of liver disease (OR 7.84, 95%CI 3.89-15.78, P < 0.001) (Supplementary Figure 2). Therefore, the AST elevation had a reliable correlation with a history of liver disease, and a potential correlation with age over 30 years.

    In summary, obesity and a history of liver disease were risk factors for abnormal liver test results, and male sex and age over 30 years were potential risk factors. These findings are of great clinical significance for evaluating high-risk subjects with liver abnormalities among asymptomatic and mild COVID-19 patients.

    Association between viral shedding time and liver test abnormalities

    The association between the viral shedding time and abnormal liver test results was analyzed in 657 participants after excluding 4 subjects with missing data. As shown in Table 2, the viral shedding time of patients with AST ≥ 2 × ULN were significantly prolonged (< 2 × ULN vs ≥ 2 × ULN, viral shedding time: 10.51 ± 2.76 d vs 12.40 ± 3.57 d, P = 0.033). As suggested by three models in Figure 3, AST ≥ 2 × ULN had a reliable correlation with the viral shedding time (univariate linear regression: coefficient 1.893, 95%CI 0.158-3.628, P = 0.033; multivariate linear regression of key factors: coefficient 1.862, 95%CI 0.140-3.584, P = 0.034; multivariate linear regression for all factors: coefficient 2.778, 95%CI 0.615-4.942, P= 0.012). In contrast, there was no significant correlation between ALT elevation and the viral shedding time. In addition, mild cases or female sex were associated with a longer viral shedding time (Table 2, Figure 3).

    Figure 2 Logistic regression models on factors associated with liver tests. A: Univariate logistic regression model; B: Multivariate logistic regression model on key factors; C: Multivariate logistic regression model on all factors; age: vs age 14-29 years; GI: Gastrointestinal; NSAIDs: Nonsteroidal anti-inflammatory drugs; OR: Odds ratio; CI: Confidence interval.

    Figure 3 Linear regression models on factors associated with viral shedding time. A: Univariate logistic regression model; B: Multivariate logistic regression model on key factors; C: Multivariate logistic regression model on all factors; age: vs age 14-29 years; ULN: Upper limit of normal; Coef.: Coefficient; CI:Confidence interval.

    Table 2 Comparison of viral shedding time by liver tests and other characteristics

    The correlations between the AST elevation or disease types and the viral shedding time were further analyzed. As shown in Supplementary Table 2, the viral shedding time of mild cases with AST ≥ 2 × ULN was significantly prolonged (AST ≥ 2 × ULN & mild cases vs AST < 2 × ULN & mild cases vs AST < 2 × ULN & asymptomatic carriers: 12.40 ± 3.57 d vs 10.59 ± 2.71 d vs 9.26 ± 3.16 d, P = 0.001). Therefore, it is suggested that great attention should be given to the liver test results of asymptomatic and mild COVID-19 patients, which has crucial clinical significance for predicting the viral shedding time.

    DISCUSSION

    To the best of our knowledge, this is the first clinical study focusing on liver test abnormalities in asymptomatic and mild COVID-19 patients. In the current epidemic of the Omicron BA2.2 variant, 12.6% of COVID-19 patients developed liver test abnormalities, and 0.9% developed liver injuries. The majority of the liver test abnormalities were mild. The ratio of abnormal liver tests in our study was lower than previous data of 14%-69%[2,3]. One possible reason for this was that our participants were all asymptomatic carriers or mild cases, among whom abnormal liver test results were uncommon. Previous studies revealed normal ALT and AST levels in asymptomatic patients, which were significantly lower than those with symptomatic infection[16]. In contrast, our study showed no differences in liver tests between asymptomatic carriers and mild cases. The probable reason was that all of the symptomatic patients in our study were mild cases, which weakened the difference between the two groups.

    As shown in our study, the risk factors for liver test abnormalities in asymptomatic and mild COVID-19 patients included obesity and a history of liver disease, and the potential risk factors included male sex and age over 30 years. Previous studies suggested that preexisting chronic liver diseases, such as NAFLD, chronic hepatitis B, and alcoholic liver disease, were high-risk factors for liver injury in COVID-19[17-19]. Consistent with these findings, our study verified a strong correlation between abnormal liver test results and a history of liver disease. Virus-induced cytokine storms, impaired mitochondrial activity, or endoplasmic reticulum stress may aggravate the preexisting liver disease, which further leads to the progression of liver injury[20]. In addition, liver test abnormalities were more common in males, which was similar to a previous study[21]. The higher estrogen level in females may play a protective role[22]. In addition, elevated ALT was strongly associated with obesity. This may be due to a high ratio of NAFLD patients among obese individuals, and fatty liver diseases can result in elevated ALT levels[18]. There was a potential correlation between elevated AST and age over 30 years. Since AST is known to reflect the injury of organs, such as myocardium and skeletal muscle, these organic injuries may occur more frequently in elderly patients with COVID-19.

    Medications for COVID-19 treatment, such as antibiotics and antiviral medications (e.g., lopinavir/ritonavir) have been reported to cause liver injury[10]. This study focused on the liver test features of COVID-19 patients in the early stage of the disease. These patients had rarely taken antibiotics or antiviral medications, while some had taken Chinese medicine, NSAIDs or other cold medicines for a short period. Importantly, no association was found between these medications and liver test abnormalities in COVID-19 patients.

    As reported in hospitalized COVID-19 patients, abnormal liver test results at admission were associated with a prolonged hospitalization time and viral shedding time[10,11]. Early elevation of AST was closely related to mortality, suggesting that it might be a predictor of poor prognosis for COVID-19[23]. Similarly, we also found a reliable association between the increase in AST and a prolonged viral shedding time in asymptomatic and mild COVID-19 patients. We speculate that the lower immunity of patients with elevated AST levels might affect the viral clearance. The viral shedding time was even longer in mild cases with elevated AST. Similar results have been previously revealed in which the viral shedding duration was longer in symptomatic patients than in asymptomatic patients[16,24]. Lymphocyte-mediated immune responses may play a vital role[15].

    Our study has two advantages. First, unlike studies concerning severe cases[2,4,15,23], we focused on the association between liver test results and viral shedding time, especially in patients infected with the Omicron BA2.2 variant, with a relatively high proportion of asymptomatic carriers and mild cases. The viral shedding time for patients with elevated AST were significantly longer, especially in mild patients. This provides crucial evidence for identifying high-risk patients with a prolonged viral shedding time. Second, we analyzed the risk factors for liver test abnormalities. Male sex, older age, obesity, and a history of liver disease may increase the risk of liver abnormalities, which can be used to identify high-risk patients with abnormal liver test results.

    One limitation of our research is that we only measured the levels of ALT, AST, and TBIL, but failed to obtain other liver test results, such as γ-glutamyl transpeptidase and alkaline phosphatase, and we did not monitor the dynamic alterations of the liver tests. The absence of these indicators may have led to an incomplete assessment of liver abnormalities. Another limitation is that we only recruited participants from two makeshift hospitals in Ningbo, but not from multiple regions. This may have led to a limited sample size and underrepresentation of the sample.

    CONCLUSION

    We evaluated the liver test features of asymptomatic and mild COVID-19 patients during the epidemic of the Omicron BA2.2 variant. Patients with a history of liver disease or male patients were more likely to develop liver test abnormalities or liver injury. Those who were obese or had a history of liver disease tended to develop ALT elevation, and those who were aged over 30 years or had a history of liver disease tended to develop AST elevation. The increase in AST in the early stage was closely associated with a prolonged viral shedding time, especially in mild cases. Attention should be given to the liver test data of asymptomatic and mild COVID-19 patients, which has important clinical significance for evaluating the viral shedding time.

    ARTICLE HIGHLIGHTS

    FOOTNOTES

    Author contributions: Yu SY designed the study and drafted the manuscript; Yu SY, Luo JJ, Lu HP and Wang JJ organized the data; Yu SY and Xie JR performed the statistical analyses; Chen XQ and Xu L supervised the study design and conduction.

    Supported by the Ningbo Medical Science and Technology Program, No. 2019Y32; Ningbo 2025 Science and Technology Major Project, No. 2021Z018; and Ningbo Natural Science Foundation of China, No. 2021J263.

    Institutional review board statement: This study was approved by the Ethics Committee of Ningbo First Hospital (No. 2022RS069).

    Informed consent statement: The data of our study was collected retrospectively, and the informed consent was exempted by the Ethics Committee of Ningbo First Hospital.

    Conflict-of-interest statement: All the authors declare that they have no conflict of interest.

    Data sharing statement: No additional data are available.

    Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin: China

    ORCID number: Si-Yi Yu 0000-0002-8295-1066; Jia-Rong Xie 0000-0002-1262-3411; Xue-Qin Chen 0000-0002-1828-1985.

    S-Editor: Liu JH

    L-Editor: A

    P-Editor: Liu JH

    亚洲成人久久性| 精品少妇一区二区三区视频日本电影| 韩国精品一区二区三区| 99精品欧美一区二区三区四区| 精品国产乱码久久久久久男人| 欧美乱妇无乱码| 大码成人一级视频| 欧美日韩国产mv在线观看视频| 在线观看66精品国产| 亚洲第一av免费看| 中文字幕人妻丝袜制服| 桃色一区二区三区在线观看| 精品卡一卡二卡四卡免费| 亚洲精品中文字幕在线视频| 国产免费av片在线观看野外av| 51午夜福利影视在线观看| 日韩一卡2卡3卡4卡2021年| 日韩大尺度精品在线看网址 | 亚洲成人免费电影在线观看| 国产精品免费一区二区三区在线| 男人的好看免费观看在线视频 | 黄片小视频在线播放| 国产精品av久久久久免费| 欧美日韩一级在线毛片| 黄色毛片三级朝国网站| 国产高清视频在线播放一区| 国产欧美日韩精品亚洲av| 久久精品91无色码中文字幕| 91大片在线观看| 久久精品亚洲熟妇少妇任你| 巨乳人妻的诱惑在线观看| 极品教师在线免费播放| 中文字幕色久视频| 国产熟女xx| 欧美亚洲日本最大视频资源| 久久久水蜜桃国产精品网| 国产精品偷伦视频观看了| 国产aⅴ精品一区二区三区波| 欧美不卡视频在线免费观看 | 欧美丝袜亚洲另类 | 久久精品亚洲精品国产色婷小说| 三上悠亚av全集在线观看| 国产精品免费一区二区三区在线| 中文字幕人妻熟女乱码| 午夜日韩欧美国产| 成人国产一区最新在线观看| 俄罗斯特黄特色一大片| 中文字幕色久视频| 两性午夜刺激爽爽歪歪视频在线观看 | 亚洲少妇的诱惑av| 性色av乱码一区二区三区2| 日本撒尿小便嘘嘘汇集6| 麻豆一二三区av精品| 纯流量卡能插随身wifi吗| 亚洲精品美女久久久久99蜜臀| 一区二区三区精品91| 高清在线国产一区| 999久久久精品免费观看国产| 欧美老熟妇乱子伦牲交| 一区在线观看完整版| 91老司机精品| 不卡一级毛片| 成人亚洲精品一区在线观看| 欧美中文日本在线观看视频| www日本在线高清视频| 欧美av亚洲av综合av国产av| 久久久久久久久久久久大奶| 久久久久久久久免费视频了| 成人av一区二区三区在线看| 国产免费现黄频在线看| 首页视频小说图片口味搜索| 欧美精品啪啪一区二区三区| 18禁国产床啪视频网站| 成年人黄色毛片网站| 国产精品一区二区免费欧美| 久久 成人 亚洲| 亚洲熟女毛片儿| 神马国产精品三级电影在线观看 | netflix在线观看网站| 神马国产精品三级电影在线观看 | 一级黄色大片毛片| 1024香蕉在线观看| 久久久国产成人免费| 人人妻人人添人人爽欧美一区卜| 自线自在国产av| 亚洲性夜色夜夜综合| av片东京热男人的天堂| 一边摸一边抽搐一进一出视频| 亚洲国产看品久久| 午夜免费激情av| 欧美久久黑人一区二区| 久久人人97超碰香蕉20202| 欧美日韩中文字幕国产精品一区二区三区 | 99热国产这里只有精品6| 丁香六月欧美| 国产三级在线视频| 国产成人精品久久二区二区91| av网站在线播放免费| 老熟妇乱子伦视频在线观看| 88av欧美| 很黄的视频免费| 91九色精品人成在线观看| 国产在线观看jvid| 日韩大码丰满熟妇| 人妻久久中文字幕网| 老司机在亚洲福利影院| 久久天堂一区二区三区四区| 日韩av在线大香蕉| 国产欧美日韩一区二区精品| 男女下面进入的视频免费午夜 | 久久午夜综合久久蜜桃| 一边摸一边抽搐一进一出视频| 色在线成人网| 久久香蕉国产精品| av超薄肉色丝袜交足视频| 日韩高清综合在线| 精品久久蜜臀av无| 成人永久免费在线观看视频| 在线观看66精品国产| 久久人人精品亚洲av| 精品人妻在线不人妻| 欧美日本中文国产一区发布| 满18在线观看网站| 久久久久久亚洲精品国产蜜桃av| 国产99久久九九免费精品| 9热在线视频观看99| 日韩欧美国产一区二区入口| 精品电影一区二区在线| 热re99久久精品国产66热6| 少妇粗大呻吟视频| 91成人精品电影| 日本黄色日本黄色录像| 亚洲一区二区三区欧美精品| 成人国语在线视频| 精品高清国产在线一区| 97碰自拍视频| 日本黄色日本黄色录像| 亚洲人成电影免费在线| 亚洲中文日韩欧美视频| 成人国产一区最新在线观看| 亚洲男人天堂网一区| 少妇裸体淫交视频免费看高清 | 久久久国产一区二区| 国产成+人综合+亚洲专区| ponron亚洲| 一进一出好大好爽视频| 亚洲av电影在线进入| 青草久久国产| 国产激情欧美一区二区| 国产又爽黄色视频| 久9热在线精品视频| 在线国产一区二区在线| 国产免费av片在线观看野外av| av超薄肉色丝袜交足视频| 黄色a级毛片大全视频| 人人妻,人人澡人人爽秒播| 欧美日韩乱码在线| 国产精品一区二区免费欧美| 免费看a级黄色片| 亚洲国产欧美一区二区综合| 久久国产亚洲av麻豆专区| 亚洲成人免费av在线播放| 免费搜索国产男女视频| 国产成人免费无遮挡视频| 亚洲美女黄片视频| 欧美成狂野欧美在线观看| 午夜日韩欧美国产| 亚洲,欧美精品.| 国产国语露脸激情在线看| 亚洲专区字幕在线| 天堂动漫精品| 美女 人体艺术 gogo| 午夜日韩欧美国产| 国产精品影院久久| 少妇裸体淫交视频免费看高清 | 午夜福利影视在线免费观看| 亚洲精品在线观看二区| 岛国视频午夜一区免费看| av超薄肉色丝袜交足视频| 国产激情久久老熟女| 久久精品91蜜桃| 亚洲性夜色夜夜综合| www.熟女人妻精品国产| 女人高潮潮喷娇喘18禁视频| tocl精华| 亚洲午夜精品一区,二区,三区| 亚洲激情在线av| 99香蕉大伊视频| 久久精品亚洲精品国产色婷小说| 久久精品影院6| 久久久久久亚洲精品国产蜜桃av| 一级a爱视频在线免费观看| 欧美日本中文国产一区发布| 高清在线国产一区| 在线观看一区二区三区激情| av福利片在线| 又紧又爽又黄一区二区| 久久精品国产亚洲av高清一级| 黄片播放在线免费| 美女午夜性视频免费| 国产熟女午夜一区二区三区| 757午夜福利合集在线观看| 午夜福利,免费看| x7x7x7水蜜桃| 久久久久久免费高清国产稀缺| 成在线人永久免费视频| 淫妇啪啪啪对白视频| 男女午夜视频在线观看| 午夜精品在线福利| 亚洲专区字幕在线| 色综合站精品国产| av天堂久久9| 婷婷精品国产亚洲av在线| 一级,二级,三级黄色视频| 看黄色毛片网站| 久久精品aⅴ一区二区三区四区| 女警被强在线播放| 黑人巨大精品欧美一区二区mp4| 久久精品人人爽人人爽视色| 国内久久婷婷六月综合欲色啪| 99久久久亚洲精品蜜臀av| а√天堂www在线а√下载| 午夜免费鲁丝| 婷婷六月久久综合丁香| 久久久久久亚洲精品国产蜜桃av| 精品人妻1区二区| 99国产综合亚洲精品| 黄色丝袜av网址大全| www.自偷自拍.com| 嫁个100分男人电影在线观看| 一本综合久久免费| 亚洲精品粉嫩美女一区| 欧美另类亚洲清纯唯美| 日韩精品青青久久久久久| 中亚洲国语对白在线视频| netflix在线观看网站| a级片在线免费高清观看视频| 性少妇av在线| 18禁观看日本| 久久九九热精品免费| www日本在线高清视频| 国产精品九九99| 午夜久久久在线观看| 999久久久国产精品视频| 久久精品91无色码中文字幕| 亚洲国产精品合色在线| 国产精品自产拍在线观看55亚洲| 中文字幕av电影在线播放| 午夜a级毛片| 国产成人av教育| 一级黄色大片毛片| 久久亚洲真实| 两性午夜刺激爽爽歪歪视频在线观看 | 女人精品久久久久毛片| 女人被躁到高潮嗷嗷叫费观| 国产色视频综合| 亚洲va日本ⅴa欧美va伊人久久| 成年人免费黄色播放视频| 男女高潮啪啪啪动态图| 在线观看免费视频网站a站| 黄色片一级片一级黄色片| 久热爱精品视频在线9| 91av网站免费观看| 亚洲欧美一区二区三区久久| 成人免费观看视频高清| 欧美最黄视频在线播放免费 | 欧美成人免费av一区二区三区| 12—13女人毛片做爰片一| 国产成人精品久久二区二区91| 亚洲中文日韩欧美视频| 国产精品九九99| 91大片在线观看| 午夜福利欧美成人| 99久久综合精品五月天人人| 久久久久亚洲av毛片大全| 桃红色精品国产亚洲av| 国产精品国产高清国产av| 日韩视频一区二区在线观看| 人人妻人人添人人爽欧美一区卜| 丰满的人妻完整版| 免费av中文字幕在线| 亚洲少妇的诱惑av| 精品无人区乱码1区二区| 亚洲中文字幕日韩| a级毛片在线看网站| 久久精品国产综合久久久| 亚洲成av片中文字幕在线观看| √禁漫天堂资源中文www| 新久久久久国产一级毛片| 99精品久久久久人妻精品| 国产亚洲精品久久久久久毛片| 一夜夜www| 亚洲av片天天在线观看| 90打野战视频偷拍视频| 丁香六月欧美| 国产欧美日韩精品亚洲av| 国产人伦9x9x在线观看| 午夜福利欧美成人| 久久久国产一区二区| 色在线成人网| 亚洲一区高清亚洲精品| 色在线成人网| 女人被狂操c到高潮| 成人特级黄色片久久久久久久| 在线天堂中文资源库| 国产精品国产av在线观看| 亚洲精品一卡2卡三卡4卡5卡| 啦啦啦 在线观看视频| 18美女黄网站色大片免费观看| 丰满迷人的少妇在线观看| 99久久人妻综合| 免费搜索国产男女视频| 夫妻午夜视频| 色哟哟哟哟哟哟| 国产一区二区激情短视频| bbb黄色大片| 美女国产高潮福利片在线看| 亚洲熟妇中文字幕五十中出 | 日韩高清综合在线| 国产99久久九九免费精品| 久久国产乱子伦精品免费另类| 亚洲九九香蕉| 欧美中文综合在线视频| 国产精品一区二区免费欧美| 日韩精品青青久久久久久| а√天堂www在线а√下载| 亚洲欧美激情综合另类| 亚洲一区中文字幕在线| 亚洲男人天堂网一区| 亚洲成a人片在线一区二区| 咕卡用的链子| 久久人人精品亚洲av| 国产精品 国内视频| 精品一区二区三区av网在线观看| 久久久久国产精品人妻aⅴ院| 亚洲成人国产一区在线观看| 亚洲精华国产精华精| 欧美久久黑人一区二区| 精品福利观看| 午夜免费观看网址| 欧美日韩一级在线毛片| 免费一级毛片在线播放高清视频 | 日本 av在线| 成人手机av| 精品卡一卡二卡四卡免费| 在线观看一区二区三区| 国产av又大| 两性午夜刺激爽爽歪歪视频在线观看 | 亚洲精品中文字幕一二三四区| 亚洲av片天天在线观看| 亚洲九九香蕉| 欧美国产精品va在线观看不卡| 久久久精品欧美日韩精品| 久久国产亚洲av麻豆专区| 欧美激情极品国产一区二区三区| 亚洲中文日韩欧美视频| 国产av精品麻豆| 久久久久久久久中文| 国产免费现黄频在线看| 色综合婷婷激情| 成人亚洲精品一区在线观看| 搡老熟女国产l中国老女人| 嫩草影院精品99| 一级毛片高清免费大全| 国产免费现黄频在线看| 香蕉久久夜色| 欧美日韩乱码在线| 亚洲午夜精品一区,二区,三区| 最近最新中文字幕大全免费视频| 亚洲色图av天堂| 夜夜爽天天搞| 又紧又爽又黄一区二区| 久久九九热精品免费| 不卡一级毛片| 欧美成狂野欧美在线观看| 欧美日韩黄片免| 久久性视频一级片| 色哟哟哟哟哟哟| 午夜精品久久久久久毛片777| 少妇粗大呻吟视频| 国产成人av教育| 波多野结衣高清无吗| 热99re8久久精品国产| 神马国产精品三级电影在线观看 | 精品国产亚洲在线| 国产av又大| 欧美日韩亚洲高清精品| 99久久国产精品久久久| 午夜免费成人在线视频| 女人被狂操c到高潮| 天天影视国产精品| 黑人猛操日本美女一级片| 久久天堂一区二区三区四区| 人妻丰满熟妇av一区二区三区| 99国产精品免费福利视频| 黄色a级毛片大全视频| 亚洲精品美女久久av网站| 久久青草综合色| 久久精品影院6| 在线观看免费高清a一片| 亚洲中文av在线| 一级毛片高清免费大全| 欧美日韩乱码在线| 国产精品一区二区精品视频观看| 青草久久国产| 97碰自拍视频| 精品欧美一区二区三区在线| 国产高清激情床上av| 黑人猛操日本美女一级片| 久热这里只有精品99| 精品日产1卡2卡| 国产又色又爽无遮挡免费看| 欧美大码av| 十八禁网站免费在线| 久久国产亚洲av麻豆专区| 成在线人永久免费视频| 日韩精品中文字幕看吧| 亚洲一区二区三区欧美精品| 免费在线观看影片大全网站| 美女 人体艺术 gogo| 久久人人精品亚洲av| 精品日产1卡2卡| av视频免费观看在线观看| 正在播放国产对白刺激| 亚洲熟妇熟女久久| 亚洲一区二区三区不卡视频| 国产成人精品无人区| 97人妻天天添夜夜摸| 18美女黄网站色大片免费观看| 在线观看www视频免费| 波多野结衣一区麻豆| 三上悠亚av全集在线观看| 性少妇av在线| 精品一品国产午夜福利视频| 久久伊人香网站| 一级a爱片免费观看的视频| 久久久精品国产亚洲av高清涩受| 亚洲 欧美 日韩 在线 免费| 国内毛片毛片毛片毛片毛片| 看片在线看免费视频| 少妇被粗大的猛进出69影院| 色婷婷av一区二区三区视频| 国产99白浆流出| 又大又爽又粗| 成年版毛片免费区| 极品教师在线免费播放| 国产成人免费无遮挡视频| 99精品欧美一区二区三区四区| 正在播放国产对白刺激| 精品一品国产午夜福利视频| 国产亚洲欧美在线一区二区| 18美女黄网站色大片免费观看| 精品一区二区三区视频在线观看免费 | 亚洲国产中文字幕在线视频| 国产91精品成人一区二区三区| 久久青草综合色| 黑丝袜美女国产一区| 欧美激情久久久久久爽电影 | 91大片在线观看| 亚洲精品粉嫩美女一区| 超碰成人久久| 麻豆av在线久日| 久久久久久免费高清国产稀缺| 在线观看日韩欧美| 色在线成人网| 伦理电影免费视频| 亚洲精品美女久久av网站| 欧美日韩国产mv在线观看视频| av在线天堂中文字幕 | 叶爱在线成人免费视频播放| 一级a爱视频在线免费观看| 亚洲色图 男人天堂 中文字幕| 18禁观看日本| av网站在线播放免费| 99热只有精品国产| 麻豆一二三区av精品| 国产亚洲精品久久久久5区| 亚洲色图av天堂| 成人黄色视频免费在线看| 大型黄色视频在线免费观看| av网站在线播放免费| 欧美黑人欧美精品刺激| 亚洲午夜理论影院| 一级,二级,三级黄色视频| 午夜视频精品福利| 色综合欧美亚洲国产小说| 亚洲av美国av| 亚洲av片天天在线观看| a级毛片在线看网站| 欧美日韩亚洲高清精品| 大码成人一级视频| 国产精品一区二区三区四区久久 | 国产成人欧美在线观看| 免费av毛片视频| 成人精品一区二区免费| 免费搜索国产男女视频| 老熟妇仑乱视频hdxx| 成人国语在线视频| 精品乱码久久久久久99久播| 在线观看舔阴道视频| 久久精品91无色码中文字幕| 好男人电影高清在线观看| www国产在线视频色| 精品一区二区三卡| 欧美另类亚洲清纯唯美| 婷婷精品国产亚洲av在线| 亚洲成人精品中文字幕电影 | 日韩大尺度精品在线看网址 | 亚洲黑人精品在线| 无限看片的www在线观看| 欧美激情高清一区二区三区| 老司机亚洲免费影院| 老鸭窝网址在线观看| 色老头精品视频在线观看| 大陆偷拍与自拍| 高清欧美精品videossex| 最近最新中文字幕大全免费视频| 中文字幕精品免费在线观看视频| 黄色视频,在线免费观看| 久久精品国产综合久久久| 88av欧美| 国产成人av激情在线播放| 1024香蕉在线观看| 色尼玛亚洲综合影院| 午夜福利一区二区在线看| avwww免费| 老司机午夜福利在线观看视频| 久久人人精品亚洲av| 日本vs欧美在线观看视频| 男人舔女人的私密视频| 久9热在线精品视频| 999精品在线视频| 丝袜人妻中文字幕| 悠悠久久av| 三级毛片av免费| 国产高清视频在线播放一区| 一进一出抽搐动态| av天堂在线播放| 夜夜夜夜夜久久久久| 国产高清视频在线播放一区| 日本vs欧美在线观看视频| 亚洲成人久久性| 色婷婷av一区二区三区视频| 国产成人系列免费观看| 久久草成人影院| 精品电影一区二区在线| 久久久精品欧美日韩精品| 欧美日韩瑟瑟在线播放| 久久精品91无色码中文字幕| 亚洲三区欧美一区| 一区在线观看完整版| 嫩草影视91久久| x7x7x7水蜜桃| 成人国产一区最新在线观看| 欧洲精品卡2卡3卡4卡5卡区| 12—13女人毛片做爰片一| 国产精品美女特级片免费视频播放器 | 一a级毛片在线观看| 国产亚洲欧美精品永久| 午夜福利一区二区在线看| 国产精品一区二区免费欧美| 国产黄a三级三级三级人| 真人做人爱边吃奶动态| 国产av精品麻豆| 色婷婷久久久亚洲欧美| 亚洲精华国产精华精| 欧美日韩黄片免| 国产成人一区二区三区免费视频网站| 日韩欧美国产一区二区入口| 久久久国产成人精品二区 | 一级片'在线观看视频| 在线永久观看黄色视频| 两个人看的免费小视频| 亚洲久久久国产精品| av国产精品久久久久影院| 久久久久久久午夜电影 | 母亲3免费完整高清在线观看| 午夜视频精品福利| 黑人猛操日本美女一级片| 叶爱在线成人免费视频播放| 激情视频va一区二区三区| 国产成人欧美在线观看| 欧美激情极品国产一区二区三区| 一级a爱视频在线免费观看| 国产区一区二久久| 日本黄色日本黄色录像| 黄色成人免费大全| 日本vs欧美在线观看视频| 亚洲久久久国产精品| 成年版毛片免费区| 97超级碰碰碰精品色视频在线观看| 国产成年人精品一区二区 | 麻豆国产av国片精品| 久久精品aⅴ一区二区三区四区| 亚洲欧美一区二区三区久久| 亚洲色图 男人天堂 中文字幕| 午夜a级毛片| 在线观看舔阴道视频| 男人操女人黄网站| 国产av一区二区精品久久| 无限看片的www在线观看| 欧美日韩福利视频一区二区| 男女做爰动态图高潮gif福利片 | 亚洲欧美激情在线| 老司机福利观看| 国产一区二区三区在线臀色熟女 | 97超级碰碰碰精品色视频在线观看| 国产精品二区激情视频| 国产精品99久久99久久久不卡| 欧美黄色淫秽网站| 五月开心婷婷网| 麻豆成人av在线观看| 大码成人一级视频| 国产精品爽爽va在线观看网站 | 亚洲精品久久午夜乱码|